Next Article in Journal
The Psychological and Behavioural Correlates of Workplace Victimization
Previous Article in Journal
Modulation of the PI3K/AKT/mTOR and AMPK/TSC2/mTOR Pathways by N-Acetyl-L-Cysteine as a Protector of Embryonic Bodies from the Toxic Effect of Methylmercury
Previous Article in Special Issue
A Targeted Radiotheranostic Agent for Glioblastoma: [64Cu]Cu-NOTA-TP-c(RGDfK)
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Brain Sciences
Volume 16
Issue 5
10.3390/brainsci16050543
brainsci-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Editorial

New Advances in the Development of New Drugs and Treatment Targets for Brain Cancers (2nd Edition)

by
Luis Exequiel Ibarra
1,2,*,
Laura Natalia Milla Sanabria
1,2 and
Nuria Arias-Ramos
3
1
Instituto de Biotecnología Ambiental y Salud (INBIAS), Universidad Nacional de Rio Cuarto (UNRC) y Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Rio Cuarto X5800BIA, Argentina
2
Departamento de Biología Molecular, Facultad de Ciencias Exactas, Fisicoquímicas y Naturales, Universidad Nacional de Rio Cuarto, Rio Cuarto X5800BIA, Argentina
3
Instituto de Investigaciones Biomédicas Sols-Morreale, Consejo Superior de Investigaciones Científicas-Universidad Autónoma de Madrid (CSIC-UAM), 28029 Madrid, Spain
*
Author to whom correspondence should be addressed.
Brain Sci. 2026, 16(5), 543; https://doi.org/10.3390/brainsci16050543
Submission received: 12 May 2026 / Accepted: 19 May 2026 / Published: 21 May 2026
(This article belongs to the Special Issue New Advances in the Development of New Drugs and Treatment Targets for Brain Cancers (2nd Edition))
Versions Notes

Excerpt

Note: In lieu of an abstract, this is an excerpt from the first page.

Primary tumors of the central nervous system (CNS) represent a major clinical challenge worldwide due to their high morbidity, aggressive biological behavior, and limited therapeutic options [...]

Share and Cite

MDPI and ACS Style

Ibarra, L.E.; Milla Sanabria, L.N.; Arias-Ramos, N. New Advances in the Development of New Drugs and Treatment Targets for Brain Cancers (2nd Edition). Brain Sci. 2026, 16, 543. https://doi.org/10.3390/brainsci16050543

AMA Style

Ibarra LE, Milla Sanabria LN, Arias-Ramos N. New Advances in the Development of New Drugs and Treatment Targets for Brain Cancers (2nd Edition). Brain Sciences. 2026; 16(5):543. https://doi.org/10.3390/brainsci16050543

Chicago/Turabian Style

Ibarra, Luis Exequiel, Laura Natalia Milla Sanabria, and Nuria Arias-Ramos. 2026. "New Advances in the Development of New Drugs and Treatment Targets for Brain Cancers (2nd Edition)" Brain Sciences 16, no. 5: 543. https://doi.org/10.3390/brainsci16050543

APA Style

Ibarra, L. E., Milla Sanabria, L. N., & Arias-Ramos, N. (2026). New Advances in the Development of New Drugs and Treatment Targets for Brain Cancers (2nd Edition). Brain Sciences, 16(5), 543. https://doi.org/10.3390/brainsci16050543

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop